Researchers design genetic tools to develop vaccines more efficiently for African swine fever virus (ASFV)

A synthetic genomic-based reverse genetics tool has been developed for African swine fever virus (ASFV) that helps vaccine development to reduce the economic losses. The system may also be adapted to other emerging viral threats.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE